Stock listing
A0YD8Q Stock Price, News, Filings & Events — Merck & Company, Inc.
Selected listing: A0YD8Q · LSX · EUR · DE
This page tracks Merck & Company, Inc.'s A0YD8Q:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A0YD8Q:LSX. A0YD8Q:LSX is the stock-level entry point for investors researching Merck & Company, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Merck & Company, Inc. (ticker: MRK) is a leading American pharmaceutical company with a market capitalization of approximately $323.72 billion. The company is known for its innovative healthcare solutions and commitment to improving patient outcomes. Merck develops a wide range of prescription medicines, vaccines, and biologic therapies.
- Ticker
- A0YD8Q:LSX
- Asset type
- Stock
- Market cap
- $362.35B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSX
- Currency
- EUR
Merck & Company, Inc. A0YD8Q:LSX stock context
This page tracks Merck & Company, Inc.'s A0YD8Q:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A0YD8Q:LSX. A0YD8Q:LSX is the stock-level entry point for investors researching Merck & Company, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Merck & Company, Inc. (ticker: MRK) is a leading American pharmaceutical company with a market capitalization of approximately $323.72 billion. The company is known for its innovative healthcare solutions and commitment to improving patient outcomes. Merck develops a wide range of prescription medicines, vaccines, and biologic therapies.
Latest news from Merck & Company, Inc.
Merck Canada Partners with the Montreal Museum of Fine Arts to Present the North American Premiere of Chiharu Shiota: The Soul Trembles
September 21, 2026
Merck’s KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) Approved in Japan for Subcutaneous Administration for All KEYTRUDA® (pembrolizumab) Indications Approved in Japan
September 21, 2026
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)
September 18, 2026
Merck Launches Your Hive of Whole Health to Support Whole Person Care for People Living With HIV
September 18, 2026
Merck to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
September 8, 2026
Merck & Company, Inc. earnings calls
Merck & Co., Inc. (MRK) Q2 2026 Earnings Call
August 4, 2026 · Replay with transcript and chapters
Merck & Co., Inc. (MRK) Q1 2026 Earnings Call
April 30, 2026 · Replay with transcript and chapters
Merck & Co., Inc. (MRK) Q4 2025 Earnings Call
February 3, 2026 · Replay with transcript and chapters
Merck & Co., Inc. (MRK) Q3 2025 Earnings Call
October 30, 2025 · Replay with transcript and chapters
Merck & Co., Inc. (MRK) Q2 2025 Earnings Call
July 29, 2025 · Replay with transcript and chapters
Merck & Co., Inc. (MRK) Q1 2025 Earnings Call
April 24, 2025 · Replay with transcript and chapters
Research Merck & Company, Inc.
Merck & Company, Inc. investor report
Review AI stock analysis and investor report context for A0YD8Q:LSX.
Merck & Company, Inc. company profile
View the public company page for Merck & Company, Inc. on 6ix.
Merck & Company, Inc. news
Read company news and market updates connected to Merck & Company, Inc..
Merck & Company, Inc. investor events
Find investor webinars, events, and replay context for Merck & Company, Inc..
Alternate listings
MRK:NYSE
US · USD
Alternate listing for Merck & Company, Inc.; the primary context on this page is A0YD8Q:LSX.
6MK:GETTEX
DE · EUR
Alternate listing for Merck & Company, Inc.; the primary context on this page is A0YD8Q:LSX.
MRK:BCBA
AR · ARS
Alternate listing for Merck & Company, Inc.; the primary context on this page is A0YD8Q:LSX.
6MK:XETR
DE · EUR
Alternate listing for Merck & Company, Inc.; the primary context on this page is A0YD8Q:LSX.
6MK:TRADEGATE
DE · EUR
Alternate listing for Merck & Company, Inc.; the primary context on this page is A0YD8Q:LSX.
MRK:BMV
MX · MXN
Alternate listing for Merck & Company, Inc.; the primary context on this page is A0YD8Q:LSX.
MRKD:BCBA
AR · USD
Alternate listing for Merck & Company, Inc.; the primary context on this page is A0YD8Q:LSX.
MRCK34:BMFBOVESPA
BR · BRL
Alternate listing for Merck & Company, Inc.; the primary context on this page is A0YD8Q:LSX.
1MRKX:MIL
IT · EUR
Alternate listing for Merck & Company, Inc.; the primary context on this page is A0YD8Q:LSX.
MRK:TSX
CA · CAD
Alternate listing for Merck & Company, Inc.; the primary context on this page is A0YD8Q:LSX.
MRK:NEO
CA · CAD
Alternate listing for Merck & Company, Inc.; the primary context on this page is A0YD8Q:LSX.
6MK:FWB
DE · EUR
Alternate listing for Merck & Company, Inc.; the primary context on this page is A0YD8Q:LSX.